| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $34.6M | +75.2% |
| SG&A Expense | $10.2M | +26.0% |
| Operating Income | -$44.8M | -60.9% |
| Income Tax | $0 | — |
| Net Income | -$43.9M | -58.1% |
| EPS (Basic) | -$2.56 | -32.6% |
| EPS (Diluted) | -$2.56 | -32.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.8M | -83.8% |
| Short-term Investments | $56.8M | +40.7% |
| Current Assets | $69.8M | -35.6% |
| Total Assets | $70.6M | -35.2% |
| Current Liabilities | $8.8M | +61.0% |
| Stockholders' Equity | $61.5M | -40.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.1M | -54.1% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$17.1M | +58.1% |
| Financing Cash Flow | -$444K | -100.6% |
| Free Cash Flow | -$38.1M | -54.0% |